[HTML][HTML] Editor's choice–vascular access: 2018 clinical practice guidelines of the European Society for Vascular Surgery (ESVS)

J Schmidli, MK Widmer, C Basile, G de Donato… - European Journal of …, 2018 - ejves.com
CHF Congestive heart failure CKD Chronic kidney disease CO Cardiac output CO2 Carbon
dioxide CPR Cardiopulmonary recirculation CTA Computed tomography angiography CVD …

[PDF][PDF] Quality improvement guidelines for percutaneous image-guided management of the thrombosed or dysfunctional dialysis circuit

SR Dariushnia, TG Walker, JE Silberzweig… - J Vasc Interv …, 2016 - academia.edu
When the evidence of literature is weak, conflicting, or contradictory, consensus for the
parameter is reached by a minimum of 12 Standards of Practice Committee members using …

Comparison of percutaneous transluminal angioplasty with stenting for treatment of central venous stenosis or occlusion in hemodialysis patients: a systematic review …

TY Wu, CK Wu, YY Chen, CH Lin - CardioVascular and Interventional …, 2020 - Springer
Objectives A common cause of hemodialysis vascular access dysfunction, a primary cause
of morbidity and mortality in patients undergoing hemodialysis, is central venous stenosis or …

Prospective, randomized, concurrently-controlled study of a stent graft versus balloon angioplasty for treatment of arteriovenous access graft stenosis: 2-year results of …

ZJ Haskal, TF Saad, JG Hoggard, RI Cooper… - Journal of Vascular and …, 2016 - Elsevier
Purpose To present final, 2-year data from randomized comparison of an expanded
polytetrafluoroethylene stent graft (SG) and percutaneous transluminal angioplasty (PTA) for …

Paclitaxel-coated balloons for the treatment of symptomatic central venous stenosis in dialysis access: results from a randomized controlled trial

PM Kitrou, P Papadimatos, S Spiliopoulos… - Journal of Vascular and …, 2017 - Elsevier
Purpose To compare the clinically-assessed intervention-free period (IFP) of paclitaxel-
coated balloon (PCB) vs conventional balloon angioplasty (CBA) for the treatment of …

[HTML][HTML] Endovascular treatment for venous diseases: where are the venous stents?

A Schwein, Y Georg, A Lejay, P Nicolini… - Methodist DeBakey …, 2018 - ncbi.nlm.nih.gov
There is a growing need for dedicated endovascular devices to treat pathologies affecting
the venous system. However, because of a lack of research into venous diseases and …

Stent grafts provided superior primary patency for central venous stenosis treatment in comparison with angioplasty and bare metal stent: a retrospective single center …

P Quaretti, F Galli, LP Moramarco… - Vascular and …, 2016 - journals.sagepub.com
Purpose: To compare patency in dialysis patients following different endovascular treatment
of symptomatic central venous stenosis. Materials and Methods: A 10-year retrospective …

[HTML][HTML] Management of central venous stenoses and occlusions

P Kitrou, K Katsanos, D Karnabatidis - CardioVascular and Interventional …, 2023 - Springer
Symptomatic central venous stenosis and occlusion remains the gordian knot of vascular
access. Advances in techniques, like sharp recanalization, allowed for improved success …

Central venous stenosis is more often symptomatic in hemodialysis patients with grafts compared with fistulas

SO Trerotola, S Kothari, TE Sammarco… - Journal of Vascular and …, 2015 - Elsevier
Purpose To determine whether hemodialysis patients with central venous stenosis (CVS)
are more frequently symptomatic if they have grafts versus fistulas. Materials and Methods A …

[HTML][HTML] Central venous disease in hemodialysis patients

HS Park, J Choi, JH Baik - Kidney research and clinical practice, 2019 - ncbi.nlm.nih.gov
Central venous disease (CVD) is difficult to treat and often resistant to treatment. In CVD,
hemodialysis vascular access should sometimes be abandoned, or in serious cases, the …